March 2, 2017

VUMC Limited Submission Opportunities: 2017 V Foundation Awards

Vanderbilt University Medical Center has been invited to participate in three V Foundation 2017 Awards: the V Translational Research Award; the Pediatric Cancer Translational Award; and the Pediatric Cancer V Scholar Award. All are limited submission opportunities; please read carefully about each call below. All internal proposals are due March 6.

V Translational Research Award

The Translational Research award is a $600,000 grant awarded in three annual installments of $200,000. (Indirect costs up to a maximum of 10 percent within the total award are permitted.)

VUMC may nominate two candidates for this award, if at least one of the two nominee applicants is submitting a research project that focuses on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in cancer causes, aggressiveness, treatment, or relapse.  Minorities for the purposes of this application are defined as African Americans or people of African descent, Pacific Islanders, Hispanic Americans, Native Americans and Alaskan Natives. 

Any area of cancer research is permitted.  However, research on cancers that are more prevalent or aggressive in specific ethnic populations is encouraged, but not required. Cancers in which ethnic and racial disparities have previously been shown include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver.  As in 2016, among our highly ranked finalists for the 2017 Translational Award program, we will designate at least one of the highest ranked applications as the recipient of a Stuart Scott Memorial Fund Translational Research Award. While not required, we have a special interest in supporting immune oncology and immunotherapy research, when applicable.

Applicant Eligibility: By the due date of the application (April 11), applicants who will lead proposed research team must have all the following:

  • Be scientists who hold a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team. 
  • Applicants must be either U.S. citizens or have a legal permit to work in the USA (either temporary or permanent).

 

Pediatric Cancer Translational Research Award

The Pediatric Cancer Translational Research award is a $600,000 grant awarded in three annual installments of $200,000. (Indirect costs up to a maximum of 10 percent within the total award are permitted.)

VUMC may nominate one candidate for this award. The single nominee may apply in either the V Scholar or the Translational program type for support. This pediatric call is distinct from the V Foundation “all cancers” call for V Scholars and Translational awards (non-pediatric specific) which will have a separate invited call for applications.

Applicant Eligibility:  By the due date of the application, applicants who will lead this research team must have all the following:

  • Be scientists who hold a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
  • Applicants must be either US citizens or have a legal permit to work in the USA (either temporary or permanent).

Please note: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

Pediatric Cancer V Scholar Award

The Pediatric Cancer V Scholar Grant supports young tenure-track faculty to begin their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. The total amount of the grant is $200,000 awarded in two annual installments of $100,000, each.

VUMC may nominate one applicant for the Pediatric Cancer V Scholar program. The single nominee may apply in either the V Scholar or the V Translational program type for support in this pediatric cancer research focused call for applications. Note: this pediatric call is distinct from the “all cancers” call for V Scholars and Translational awards (non-pediatric specific) which will have a separate invited call for applications.

Applicant Eligibility: All nominated applicants must meet all of the following criteria to be eligible to submit an application:

  • Must have at least 2 years post-doctoral (M.D. or Ph.D.) fellowship training. For M.D.s, a minimum of one year is acceptable if only one year is required for the specialty.
  • By the due date of the application, applicants must have all the following:
    • Hold a tenure-track faculty position as an assistant professor at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for this grant competition. 
    • Have been appointed to their first full-time assistant professor faculty position within the last 5 years, and not yet been promoted to associate professor.
    • Clinical scientists are eligible if VICC can demonstrate that it will fully support the research applicant (e.g., dedicated lab space, start-up funds, and dedicated research time).
    • Applicants must be either U.S. Citizens or permanent legal residents in the U.S. 
  • As of the due date of the application (May 2), applicants who have been awarded RO1 equivalent grants (project leader on an NIH multi-investigator grant, ACS) as principal investigators or as co-leader at the time of application submission are NOT eligible for consideration as a V Scholar. In addition, applicants cannot be a co-leader on a SPORE project or (co)PI of the following NIH grant mechanisms: U01, DP1, DP2, R37, R23. In addition, principal investigators for research project grants (RPGs), analogous to NIH/NCI R01 awards, would be ineligible.

 

 
 

 

 

 

Anyone interested in being considered as Vanderbilt’s nominee for any of the above must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on Wednesday, March 1.

  1. Brief (2 page maximum) research plan including summary budget;
  2. Brief statement of support from department chair/center director;
  3. A brief CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email. 

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominees will submit full proposals to the foundation by the April 11 (for Translational Research award) or the May 2 (both pediatric cancer award) deadlines.

If you have any questions about the foundation or its interests and priorities, please contact Megan Smallwood in the Office of Research or Adele White in the Corporate and Foundation Relations Office.